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Limb muscles of vertebrates are derived from precursor cells that migrate from the lateral edge of the dermomyotome into the limb bud.
Although several signaling molecules have been reported to be involved in the process of limb myogenesis, none of their activities has led to a
consolidate idea about the limb myogenic pathway. Particularly, the role of ectodermal signals in limb myogenesis is still obscure. Here, we
investigated the role of the ectoderm and ectodermal Wnt-6 during limb muscle development. We found that ectopic expression of Wnt-6 in the
limb bud specifically extends the expression domains of Pax3, Paraxis, Myf5, Myogenin, Desmin and Myosin heavy chain (MyHC) but inhibits
MyoD expression. Ectoderm removal results in a loss of expression of all of these myogenic markers. We show that Wnt-6 can compensate the
absence of the ectoderm by rescuing the expression of Pax3, Paraxis, Myf5, Myogenin, Desmin and MyHC but not MyoD. These results show
that, in chick, at least two signals from the limb ectoderm are necessary for muscle development. One of the signals is Wnt-6, which plays a unique
role in promoting limb myogenesis via Pax3/Paraxis –Myf5, whereas the other putative signaling pathway involving MyoD expression is
negatively regulated by Wnt-6 signaling.
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Myogenic cells forming striated skeletal muscles of the
vertebrate body originate from the somites. Cell lineage
experiments have shown that the ventral part of the somites,
forming the sclerotome, gives rise to the axial skeleton and ribs
and that their dorsal part or dermomyotome differentiates into
skeletal muscles and dermis (Christ and Ordahl, 1995).
Precursors of limb musculature are provided by the lateral
portion of somites at the level of the limb buds (Christ et al.,
1974, 1977; Chevallier et al., 1977; Ordahl and Le Douarin,
1992). These progenitor cells migrate from the dermomyotome
towards the limb. Development of limb musculature proceeds
in several steps including de-epithelialization of the lateral
dermomyotomal lip, migration of progenitor cells to the limb
bud, homing into the prospective muscle regions, myogenic0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.09.035
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E-mail address: bodo.christ@anat.uni-freiburg.de (B. Christ).specification of precursors and differentiation to functional
muscle. The migrating cells express the transcription factors
Pax3, Lbx1 and Pax7 and populate the limb bud, where they
start to express myogenic differentiation factors MyoD and
Myf5 (Buckingham, 2003; Francis-West et al., 2003). The
premyogenic (Pax3 expressing) and early myogenic (MyoD/
Myf5 expressing) cells form the premuscular masses, which are
dense collections of cells located beneath the subectodermal
mesenchyme (Christ and Ordahl, 1995; Amthor et al., 1998).
MyoD, Myf5, Myogenin and MRF4 encode myogenic
regulatory factors (MRF) belonging to the bHLH family of
transcription factors. Their expression in a cell reflects the
commitment of these cells to a myogenic fate before any
cytological sign of muscle differentiation is detectable (Ott et
al., 1991; Pownall and Emerson, 1992; Sassoon, 1993; Christ
and Brand-Saberi, 2002). The signals involved in activating the
myogenic program in muscle precursor cells in the limb in vivo
are not entirely known. In chick embryos subjected to
neuralectomy and notochordectomy, cells of the medial somitic
half which will form epaxial muscle die within 24 h following88 (2005) 221 – 233
www.e
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the somite survive, migrate and differentiate. This suggests, in
the hypaxial domain, the existence of a distinct inductive
influence from the environment on the differentiation of
hypaxial skeletal muscles (Teillet and Le Douarin, 1983; Rong
et al., 1992). Lateral somitic lineage specification results from
signals emanating from the lateral plate mesoderm (Pourquie´ et
al., 1995, 1996; Cossu et al., 1996a,b) and dorsal ectoderm
(Kenny-Mobbs and Thorogood, 1987; Fan and Tessier-
Lavigne, 1994; Cossu et al., 1996a,b). Regarding limb muscle
development, the current view is that the limb surface ectoderm
produces signals which activate muscle differentiation in the
limb. The dorsal and ventral ectoderm controls the dorsoventral
polarity of the limb bud. After limb ectoderm removal, the limb
mesoderm cells differentiate into cartilage and connective
tissue but not into muscle (Searls and Smith, 1982), indicating
that surface ectoderm is necessary for limb muscle formation.
However, the signals from the ectoderm that are involved in
this process are not known.
The Wnt gene family encodes a group of signaling
molecules that are implicated in numerous aspects of morpho-
genesis in both vertebrates and invertebrates (Dickinson and
McMahon, 1992; Parr and McMahon, 1994; Nusse and
Varmus, 1992; Cadigan and Nusse, 1997; Huelsken and
Birchmeier, 2001). In vertebrates, the Wnt family of secreted
glycosylated factors consists of 22 presently known members,
which have many developmental functions ranging from
patterning of individual structures to cell differentiation,
proliferation and survival. A member of this family, Wnt-6,
has been cloned in different species including human, mouse,
Drosophila, Xenopus, Amphioxus and the chick, and its
expression pattern was analyzed (Janson et al., 2001; Schubert
et al., 2001; Itaranta et al., 2002; Schubert et al., 2002;
Rodriguez-Niedenfu¨hr et al., 2003; Loganathan et al., 2005).
At HH stages 15–16, Wnt-6 is expressed in a subset of
ectodermal cells located at the dorsoventral boundary in the
limb field which corresponds to the prospective apical
ectodermal ridge. From HH stage 17, Wnt-6 is strongly
expressed in both the dorsal and ventral limb ectoderm
including the dorsoventral boundary. The function of Wnt-6
during limb development has not yet been studied.
In order to investigate a possible role of Wnt-6 signaling in
limb muscle development, we over-expressed Wnt-6 in the
early limb bud in vivo and looked for subsequent changes in
muscle markers. We found that ectopic expression of Wnt-6
in the limb bud specifically extended the expression domains
of Pax3, Paraxis, Myf5, Myogenin, Desmin and MyHC but
down-regulated the expression of MyoD. We show that the
surface ectoderm is necessary for the expression of all
myogenic markers including MyoD irrespective of their status
of proliferation or differentiation. We demonstrate that Wnt-6-
expressing cells can compensate the absence of the ectoderm
by rescuing the expression of Pax3, Paraxis, Myf5, Myo-
genin, Desmin and MyHC but not of MyoD. We propose that
two parallel pathways exist during limb myogenesis. One
pathway acts via Pax3/Paraxis –Myf5, which is promoted by
Wnt-6 signaling from the ectoderm, and the other pathwayinvolves MyoD, which is negatively regulated by Wnt-6
signaling.Materials and methods
Preparation of chick embryos
Fertilized chicken eggs were incubated at 38-C, and the embryos were
staged according to Hamburger and Hamilton (1951).
Cloning, transfection and selection of Wnt-6-positive CHO cells
The coding sequence of chicken Wnt-6 cDNA (1.1 kb) was cloned as an
EcoRI–NotI fragment into the vector pCMS-EGFP (Clontech), which enables
transcription of the Wnt-6 cDNA and the EGFP cDNA independently by two
different promoters: the CMV promoter drives transcription of Wnt-6 and the
SV40 promoter the one of EGFP. The endotoxin-free plasmid DNA was
transfected into CHO cells by using Effectene (Qiagen) as transfection reagent.
The transfection procedure was performed according to the manufacturer’s
protocol. Positive clones were selected by their green fluorescence using a high
speed cell sorter MoFlo (DakoCytomation), excitation was performed at 488
nm using an argon laser. Stable Wnt-6-expressing CHO cell clones with bright
green fluorescence were taken for the experiments in chick embryos. In each
experimental setting, chick embryos were injected with green fluorescent
control CHO cells and incubated in parallel to the Wnt-6-expressing CHO cell
injected embryos. Green fluorescent control CHO cells were generated by
transfecting cells with empty vector pEGFP-N1 (Clontech) as described above.
Bright fluorescent cell clones were selected and cultured individually.
Cell culture and Northern blot analysis
CHO cells (CHO-GFP and CHO-Wnt6-GFP) were cultured in DMEM
culture medium (PAA-Laboratories/Co¨lbe, Germany), supplemented with 10%
fetal calf serum, 2 mM l-glutamine and 50 U/ml streptomycin/penicillin. Prior to
the experiments, the cells were trypsinized and collected in cell culture medium
to stop trypsinizing activity. Cells were pelleted by centrifugation (800 g for 3
min), washed once with phosphate-buffered saline pelleted again and used as
pellets for the operations.
To isolate total RNA, CHO cells (CHO-GFP and CHO-Wnt6-GFP) were
harvested with RLT-lysis buffer (Qiagen), supplemented with 1% h-mercap-
toethanol. RNA preparation was done according to the manufacturer’s protocol
using RNeasy Kit (Qiagen). Ten micrograms of RNA (from both CHO-GFP
cells and CHO-Wnt6-GFP cells) was loaded per lane and electrophoresed using
a 1.2% RNA–agarose gel containing 5% formamide. The gel was blotted onto
a positively charged nylon membrane using 20 SSC. The next day, the blot
was briefly washed in 2 SSC, UV cross-linked (Stratalinker, Stratagene),
stained using acidic methylene blue solution (0.04% methylenblue dissolved in
500 mM sodium acetate, pH 5.2) to visualize the loading and integrity of the
RNA and scanned for documentation.
Hybridization was performed using ExpressHyb (Becton and Dickinson).
The procedure was performed according to the manufacturer’s protocol. For
radioactive labeling, the Wnt6 fragment was excised from the vector. The 1.1
kb EcoRI-Wnt6 fragment was purified using DNA purification kit (Qiagen).
Labeling of the Wnt6 fragment was performed in the presence of 32P-dCTP
using RediPrime labeling kit (Amersham).
Injection of Wnt-6 cells
CHO cells producing Wnt-6 protein and CHO-GFP control cells were used
in parallel. Confluent cultures were harvested, cells were washed in phosphate-
buffered saline (PBS), pelleted and resuspended in a minimal volume of
medium. Experiment was performed on embryos at HH stages 21–22. For cell
injection, the ectoderm of the limb was punctured with a tungsten needle, and
concentrated cell suspensions were locally applied with a micropipette.
Embryos were reincubated for various time periods (1–3 days), processed
for whole-mount in situ hybridization and for 1–2 days used for whole-mount
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myogenic marker.
Removal of limb ectoderm
For ectoderm removal, the ectoderm was stained with nile blue sulfate in
ovo using a blunt glass needle coated with 2.5% agarose containing 2% nile
blue. The ectoderm (of HH stage 21–22) was peeled from the mesenchyme in
the dorsal side of the forelimb bud as far as possible towards the edges without
disturbing the apical ectodermal edge. After removal of ectoderm, the limb was
covered with gold foil to prevent regeneration of the ectoderm. Embryos were
reincubated for 24 h, processed for whole-mount in situ hybridization and for
36 h and 48 h used for whole-mount immunohistochemistry. Same experiment
was performed at HH stages 24–25 in some embryos, reincubated for 24 h and
were processed for whole-mount in situ hybridization.
Injection of Wnt-6 cells after ectoderm removal
Ectoderm was removed and replaced with gold foil as described before.
Then, CHO cells producing Wnt-6 protein were injected beneath the gold foil.
Embryos were reincubated for 24 h, processed for whole-mount in situ
hybridization and for 36 h and 48 h used for whole-mount immunohistochem-
istry. In some embryos, cells producing Wnt-6 protein were not injected
immediately after ectoderm removal but after a reincubation period of 24 h to
check the activity of Wnt-6 cells on myogenic markers. These embryos were
reincubated for 24 h and processed for in situ hybridization.
Whole-mount in situ hybridization
Embryos were washed in PBS and fixed overnight in 4% paraformaldehyde
at 4-C, washed twice in PBT, dehydrated in methanol and stored at 20-C.
Whole-mount in situ hybridization was performed as previously described
(Nieto et al., 1996). Selected embryos were embedded in 4% agar and sectioned
with a vibratome at 50 Am.
The following probes were used in this study: Pax-3, 645 bp fragment
corresponding to nucleotides 468–1113 (gift from Martin Goulding); full-
length Paraxis clone was a gift from Prof. Eric Olson; cMyf5 and cMyoD (1518
bp); cMyogenin (1200 bp; Fujisawa-Sehara et al., 1990) and for cWnt-6, we
used the cloned Wnt-6 1500 bp fragment (Rodriguez-Niedenfu¨hr et al., 2003),
as template.
Immunohistochemistry on whole mounts
Embryos were fixed overnight in 4% paraformaldehyde (PFA), dehydrated
in 100% methanol, incubated for 1 h in 4:1 methanol/H2O2 (6% final) and
washed in PBT (PBS containing 0.5% Triton). Embryos were treated in
Proteinase K (10 Ag/ml) and, after washing in PBT, fixed in 4% PFA for 20
min. Following a brief wash in PBT, embryos were incubated for 1 h in 10%
horse serum (in PBT) and then overnight with anti-Wnt6/anti-Desmin/MF20
antibodies (Zymed laboratories/DAKO, 1:500/cell supernatant from Hybrid-
oma Bank in horse serum/PBT respectively). Embryos were extensively
washed in PBT and then incubated overnight in secondary antibody (alkaline-
phosphatase-conjugated goat anti-mouse Ig antibody; Sigma, 1:500, in horse
serum/PBT). Subsequently, embryos were washed in PBT, transferred in
NTBT buffer (Nieto et al., 1996), incubated for 5–10 min in color reagent
(4.5 Al NBT and 3.5 Al BCIP in 1 ml NTBT-buffer; Boehringer-Mannheim),
washed in NTBT buffer, cleared in dimethylformamide and stored in 4%
PFA.
BrdU labeling
After removing the ectoderm in the limb and injection of Wnt-6-producing
cells after ectoderm removal of limb, proliferative activity was determined by
the BrdU method. For BrdU labeling, 200 Al of 40 mM BrdU (Sigma) dissolved
in water was added on the vitelline membrane 30 min before fixation, and
embryos were reincubated at 38-C. After rinsing, the embryos were fixed in a
mixture of 3% glacial acetic acid and 97% methanol and embedded in paraffin.Immunohistochemistry was performed by indirect immunoperoxidase method
with monoclonal anti-BrdU antibody (DAKO). Diaminobenzidine (DAB) was
used as chromogen, and weak counter-staining was performed with true red.Results
In vitro and in vivo evidence for the activity of
Wnt-6-producing cells
To determine that CHO-Wnt6-GFP cells expressed Wnt6,
total RNAwas isolated from the cultured cells and subjected to
Northern blot analysis using a radioactively labeled Wnt6
fragment as a probe (Fig. 1A). The data show that Wnt-6 is
highly expressed in CHO transfected cells that have been used
for further experimental settings. The activity of Wnt-6-
producing cells was shown in vivo by in situ hybridization as
well as by whole-mount immunohistochemistry by using anti-
Wnt6 antibody. Ectopic expression of Wnt-6 is seen in the
operated limb identified by in situ hybridization and whole-
mount immunohistochemistry (Figs. 1D, F, respectively). The
presence of Wnt-6-producing cells can easily be monitored by
fluorescence of a GFP reporter in the cells (Figs. 1E, G) seen in
the operated limb. Parallel experiments were performed by
injecting control CHO-GFP cells. None of the control experi-
ments influenced the expression of Wnt-6 (Fig. 1B).
Evidence for the absence of ectoderm after ectoderm removal
experiment
The ectoderm was peeled from the mesenchyme in the dorsal
side of the forelimb bud as far as possible towards the edges
without disturbing the apical ectodermal ridge. After removal of
the ectoderm, the limb was covered with gold foil to prevent
regeneration of the ectoderm. To demonstrate that the ectoderm
did not regenerate, embryos were processed for whole-mount in
situ hybridization with Wnt-6 probe as Wnt-6 is expressed only
in the limb ectoderm (Parr et al., 1993; Rodriguez-Niedenfu¨hr et
al., 2003; Loganathan et al., 2005). Removal of the ectoderm
resulted in a complete loss of Wnt-6 expression on the dorsal
side of the operated limb (Fig. 1H). The section of the operated
limb clearly shows the absence of ectoderm and Wnt-6
expression on the dorsal side, whereas the ectoderm of the
ventral side maintains Wnt-6 expression (Fig. 1J). The section
of the unoperated control limb shows normal expression ofWnt-
6 in both dorsal and ventral limb ectoderm (Fig. 1I).
Role of Wnt-6 in the specification of limb muscle cells
Wnt-6 is uniformly expressed in both the dorsal and ventral
limb ectoderm throughout development (Parr et al., 1993;
Rodriguez-Niedenfu¨hr et al., 2003; Loganathan et al., 2005).
To test a possible influence of Wnt-6 on limb muscle cells, we
injected CHO cells expressing EGFP-Wnt-6 protein into the
wing mesenchyme of embryos at HH stages 21–22. After a
reincubation period of 1–3 days, the embryos were fixed and
processed for in situ hybridization with various myogenic
markers. Some embryos were reincubated for 36 h and 48 h,
Fig. 1. In vitro and in vivo evidence that the CHO-Wnt6-GFP cells express Wnt-6. (A) Northern Blot analysis was performed by using a radioactively labeled Wnt-6
fragment. A clear positive Wnt-6 signal is seen in CHO-Wnt6-GFP cells that have been used for further experiments. The methylene-blue-stained blot (bottom)
shows that comparable amounts of total RNA were loaded per lane. The strong 28S and 18S banding pattern indicates that no RNA degradation had occurred. (B)
After implantation of CHO-GFP cells, Wnt-6 expression remains unaltered after in situ hybridization with Wnt-6 probe. (C) Confirmation of the presence of control
CHO-GFP cells by the fluorescence emitted, and the limb boundary is marked by green lines in the operated limb. (D) Ectopic expression of Wnt-6 in the operated
limb (arrowhead) after implantation of CHO-Wnt6-GFP cells. (E) Localization of CHO-Wnt6 cells is seen in the operated limb of the sample shown in panel D, and
the limb boundary is demarcated by green lines. (F) An ectopic expression of Wnt-6 (arrowhead) is seen in the operated limb identified by whole-mount
immunohistochemistry with anti-Wnt6 antibody. (G) The presence of Wnt-6-producing cells is shown by fluorescence of a GFP reporter in the operated limb of
sample shown in panel F. Ectoderm does not regenerate after ectoderm removal. (H) In situ hybridization with a Wnt-6 probe after removal of the dorsal wing
ectoderm. The arrowhead indicates a complete loss of Wnt-6 expression. (I) Transverse section of the unoperated limb of the sample seen in panel H, showing the
normal expression of Wnt-6 in both dorsal and ventral limb ectoderm. (J) The section of the operated limb clearly shows the absence of ectoderm and Wnt-6
expression in the dorsal side, whereas the ectoderm of the ventral side expressing Wnt-6 is clearly visible.
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MyHC (MF20) and anti-Desmin antibodies. We found that
over-expression of Wnt-6 leads to an up-regulation of MyHC
in the operated limb (Fig. 2A). To check for the possible
pathway of Wnt-6 signaling during limb myogenesis, weFig. 2. The ectoderm and Wnt-6 promote the expression of MyHC in the limb. (A) W
Wnt-6-producing cells beneath the ectoderm, following 36 h of reincubation. On th
CHO-Wnt6-GFP cells is shown by the green line in the operated limb. (a) Fluoresc
limb in panel A. (B) Transverse section of the unoperated limb in panel A showing no
the arrowhead marks the expansion of MyHC expression. (D) Removal of ectoderm l
the unoperated limb in panel D. (F) Loss of MyHC expression (arrowhead) after ecto
expression in the operated limb (arrowhead) after ectoderm removal and implantati
operated limb of the sample shown in panel G. (H) Section of the unoperated limb
ectoderm removal (shown in transverse section, arrowhead). The green line demarca
brackets delimit the region devoid of ectoderm.examined the expression of proliferation markers after over-
expression of Wnt-6. We detected an up-regulation of both
Pax-3 (Figs. 3A and C, n = 9) and Paraxis (Figs. 4A and C,
n = 11). We then examined the expression of differentiation
markers. After over-expression of Wnt-6, we surprisinglyhole-mount immunohistochemistry using MF20 antibody after implantation of
e operated side, MyHC expression is up-regulated (arrowhead). Localization of
ence emitted by the CHO cells expressing both GFP and Wnt-6 in the operated
rmal MyHC expression. (C) Transverse section of the operated limb in panel A,
eads to loss of MyHC expression in limb (arrowhead). (E) Transverse section of
derm removal in transverse section of the operated limb in panel D. (G) MyHC
on of Wnt-6-expressing cells. (g) Localization of CHO-Wnt6-GFP cells in the
shows normal MyHC expression. (I) Wnt-6 can rescue MyHC expression after
tes the position of cells expressing GFP-Wnt-6 in the operated limb, and black
Fig. 3. The ectoderm and Wnt-6 promote the expression of Pax3 in the limb. (A) Up-regulation of Pax3 expression (arrowhead) after injection of CHO cells
producing Wnt-6. (B) Transverse section of the unoperated limb of the embryo in panel A showing Pax3 expression. (C) Transverse section of the operated limb in
panel A showing expansion of Pax3 expression domain (arrowhead). (D) In situ hybridization with a Pax3 probe after removal of the dorsal wing ectoderm at stages
21–22 and fixation after 24 h. The arrowhead indicates a complete loss of Pax3 expression. (E) Pax3 expression in a transverse section of the unoperated limb from
panel D. (F) Loss of Pax3 expression in a transverse section of the operated limb from panel D. (G) Whole-mount in situ hybridization with a Pax3 probe after
ectoderm removal and implantation of Wnt-6-expressing cells beneath the gold foil at stages 21–22, reincubation for 24 h. The arrowhead indicates the rescue of
Pax3 expression in spite of ectodermal removal. (H) Transverse section of the unoperated limb in panel G. (I) Transverse section of the operated limb in panel G
showing rescued expression of Pax3 (arrowhead). The green line demarcates the position of cells expressing GFP-Wnt-6 in the operated limb, and black brackets
delimit the region devoid of ectoderm.
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premuscle mass after a reincubation period of 24 h (Figs. 5A
and C). Down-regulation of MyoD expression was observed
even after a reincubation period of 48 h and 72h (Figs. 5D
and G respectively).
In contrast, expression of Myf5 (n = 9), another early
marker of muscle differentiation, was up-regulated by over-
expression of Wnt-6 (Figs. 6A and C). Over-expression of
Wnt-6 led also to an up-regulation of Myogenin (Figs. 8A andFig. 4. The ectoderm and Wnt-6 promote the expression of Paraxis in the limb. (A) P
the up-regulation of Paraxis in the operated limb when compared to the control limb
A. (C) Transverse section of the operated limb in panel A, the arrowhead marks the e
the arrowhead indicates the dorsal premuscle mass. The shadow marks the expressio
without ectoderm removal showing normal expression of Paraxis. (F) Transverse s
(arrowhead). (G) In situ hybridization for Paraxis after ectoderm removal, replacem
and following reincubation of 24 h. Note the Paraxis expression in the operated li
Transverse section of the operated limb in panel G, the arrowhead marks the rescued
cells, and black brackets delimit the region where the ectoderm has been removed.C, n = 10) and Desmin (Figs. 10A and C, n = 7). Parallel
experiments were done by injecting control CHO-GFP cells
(n = 17). None of the controls influenced the expression of
any gene (Figs. 7A and B).
In summary, Wnt-6 increases the expression of Pax-3 and
Paraxis which are associated with the proliferation of
myogenic cells. Furthermore, Wnt-6 up-regulates the expres-
sion of Myf5, Myogenin, Desmin and MyHC which are
downstream of Pax3 and Paraxis and associated with musclearaxis expression after implantation with Wnt-6 cells. The arrowhead indicates
. (B) Paraxis expression in a transverse section of the unoperated limb in panel
xpansion of Paraxis expression. (D) Paraxis expression after ectoderm removal,
n in the ventral mass. (E) Transverse section of the unoperated limb in panel D
ection of the operated limb in panel D, showing the loss of Paraxis expression
ent with gold foil, implantation of Wnt-6-expressing cells beneath the gold foil
mb (arrowhead). (H) Transverse section of the unoperated limb in panel G. (I)
Paraxis expression. The green line marks the localization of CHO-GFP-Wnt-6
Fig. 5. A specific role played by Wnt-6 in limb myogenesis by inhibiting MyoD expression. (A) Over-expression of Wnt-6 leads to down-regulation of MyoD
expression in the limb (arrowhead) after a reincubation period of 24 h. (B) MyoD expression in the unoperated limb in panel A. (C) Transverse section of the
operated limb in panel A where Wnt-6 inhibits MyoD expression (arrowhead). (D and G) Whole-mount in situ hybridization for MyoD after 48 h and 72 h of
reincubation and after implantation of Wnt-6-producing cells beneath the ectoderm of the limb. Note the down-regulation of MyoD expression (arrowhead). (E and
H) Transverse section of the unoperated limb in panels D and G, respectively, showing normal MyoD expression. (F and I) Transverse section showing a down-
regulation of MyoD expression (arrowhead) in the operated limb in panels D and G, respectively. The green line demarcates the position of cells expressing GFP-
Wnt-6 in the operated limb. (J) Loss of MyoD expression after ectoderm removal in the limb (arrowhead). (K) Transverse section of the unoperated limb in panel J.
(L) Transverse section of the operated limb in panel J showing complete loss of MyoD expression (arrowhead). (M) Implantation of Wnt-6-expressing cells does not
rescue the expression ofMyoD after ectoderm removal (arrowhead). (N) Transverse section of the unoperated limb in panel M. (O) Transverse section of the operated
limb in panel M. Localization of CHO-Wnt-6-GFP cells is shown by the green line marked in the operated limb. The region without ectoderm is shown within black
brackets.
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muscle differentiation, MyoD, is reduced by Wnt-6. This
indicates that Wnt-6 differentially regulates myogenic differ-
entiation in the limb.
Signals from the limb ectoderm promote myogenesis
It has been suggested that the dorsal and ventral limb
ectoderm influences limb development (Pautou and Kieny,
1973; Stark and Searls, 1974; MacCabe et al., 1974). To
determine whether signals from the ectoderm are important for
myogenesis in the limb, dorsal wing ectoderm was removed
from embryos at HH stages 21–22, reincubated for 24 h, fixed
and processed for in situ hybridization using probes against
Pax-3 (n = 10), Paraxis (n = 13), MyoD (n = 11), Myf5 (n =
8) and Myogenin (n = 10). Embryos fixed after 36 h and 48h were used for whole-mount immunohistochemistry using
Desmin and MF20 antibodies. Removal of the ectoderm led to
the complete loss of expression of all myogenic markers
mentioned above (Figs. 3D, 4D, 5J, 6D, 8D, 10D and 2D).
Sections clearly show the loss of the expression domain of
these markers in the dorsal region of the operated limb (Figs.
3F, 4F, 5L, 6F, 8F, 10F and 2F) when compared to the control
limb (Figs. 3E, 4E, 5K, 6E, 8E, 10E and 2E). The expression
in the ventral domain was not affected. To examine whether
the ectoderm is moreover necessary for the maintenance of the
expression of myogenic markers even after the commitment of
myogenic cells to differentiation, the dorsal ectoderm of the
limb was removed at later stages (HH stages 24–25),
reincubated for 24 h and processed for in situ hybridization.
This leads to the loss of expression of MyoD, Myf5 and
Myogenin (Figs. 9A, D and G respectively), indicating that the
Fig. 6. The ectoderm and Wnt-6 promote the expression of Myf5 in the limb. (A) Application of cells producing Wnt-6 to the limb up-regulates Myf5 expression
(arrowhead). (B) Transverse section of the unoperated limb of embryo in panel A. (C) Transverse section of the operated limb in panel A showing expansion and
extension of Myf5 expression domain. (D) Ectoderm removal leads to complete loss of Myf5 expression in the limb (arrowhead). (E) Transverse section of the
unoperated limb in panel D showing normal expression of Myf5. (F) Transverse section of the operated limb in panel D showing complete loss of Myf5 expression
(arrowhead) after ectoderm removal. (G) Ectopic Wnt-6 compensates the loss of ectoderm and rescues the Myf5 expression (arrowhead). (H) Myf5 expression in the
unoperated control limb in transverse section. (I) Myf5 expression in the operated limb in panel G in a transverse section. The green line demarcates the position of
cells expressing GFP-Wnt-6 in the operated limb, and black brackets delimit the region devoid of ectoderm.
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differentiation even in late stages of limb muscle development.
As the limb was covered by gold foil after removal of the
ectoderm, the possibility of regeneration of the ectoderm could
be ruled out. The sections clearly revealed that the limb
ectoderm had not regenerated over the ablated regions. After
ectoderm removal, labeling with BrdU (n = 4) was performed
to investigate the proliferative activity of limb cells. Dorsal
wing mesenchyme from which the overlying ectoderm had
been removed showed almost no BrdU incorporation (Fig.
12B) when compared with the intact ventral side or unoperated
contralateral wing (Fig. 12A), indicating that the ectoderm
promotes myogenic proliferation in the limb. These results
show that signals from the limb ectoderm are vital for the
expression of all myogenic markers irrespective of their state
(proliferation/differentiation).
Wnt-6 can replace ectoderm promoting myogenic
differentiation and specification
Our previous observations prompted us to check if Wnt-6,
which is expressed in the limb ectoderm (Parr et al., 1993;Fig. 7. Control CHO-GFP cells do not influence the expression of any gene. (A) W
implantation of CHO-GFP-producing cells. (B) Myf5 expression remains unaltere
position of CHO-GFP control cells in the operated limb.Rodriguez-Niedenfu¨hr et al., 2003; Loganathan et al., 2005),
could be the ectodermal signal that promotes myogenesis in
the limb. We injected CHO cells expressing GFP-Wnt-6
protein into the dorsal limb mesenchyme of HH stages 21–
22 embryos after removal of the ectoderm. The embryos
were reincubated for 24 h and processed for in situ
hybridization with Pax-3 , Paraxis , MyoD , Myf5 and
Myogenin. Embryos reincubated for 36 h and 48 h were
used for whole-mount immunohistochemistry using MF20
and Desmin antibodies. We found that the expression of Pax-
3 (Fig. 3G, n = 8), Paraxis (Fig. 4G, n = 10), Myf5 (Fig.
6G, n = 7), Myogenin (Fig. 8G, n = 10), Desmin (Fig. 10G,
n = 6) and MyHC (Fig. 2G, n = 4) could be rescued by
injection of Wnt-6-producing cells after ectoderm removal.
However, the expression of MyoD (Fig. 5M, n = 10) could
not be rescued.
To check the timing of Wnt-6 activity in rescuing the
expression of myogenic markers, dorsal limb ectoderm was
removed at HH stages 21–22. After 24 h of reincubation,
Wnt-6-producing cells were injected, reincubated again for
24 h and processed for in situ hybridization. We found that
Wnt-6 rescues the expression of Myf5 and Myogenin (Figs.hole-mount in situ hybridization showing no change in MyoD expression after
d after implantation of CHO-GFP-expressing cells. The green line marks the
Fig. 8. The ectoderm and Wnt-6 promote the expression of Myogenin in the limb. (A) Up-regulation of Myogenin expression (arrowhead) after implantation of Wnt-
6-producing cells in the limb. (B) Normal Myogenin expression seen in a transverse section of the unoperated limb of embryo in panel A. (C) Transverse section of
the operated limb in panel A showing expansion of theMyogenin expression domain (arrowhead). (D) Removal of ectoderm leads to loss ofMyogenin expression in
the limb (arrowhead). (E) Transverse section of the unoperated limb in panel D. (F) Loss of Myogenin expression (arrowhead) in the transverse section of the
operated limb in panel D. (G)Myogenin expression in the operated limb (arrowhead) after ectoderm removal and implantation of Wnt-6-expressing cells. (H) Section
of the unoperated limb shows Myogenin expression. (I) Wnt-6 rescues Myogenin expression after ectoderm removal (seen in the transverse section marked by
arrowhead). The green line demarcates the position of cells expressing GFP-Wnt-6 in the operated limb, and black brackets delimit the region devoid of ectoderm.
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ectoderm removal albeit less effective than described above.
In contrast, the expression of MyoD (Fig. 11A) could not be
rescued by Wnt-6.
To check the influence of Wnt-6 on the proliferative
activity of limb cells, we labeled manipulated limbs with
BrdU (n = 5). The number of cells showing BrdU
incorporation in the operated limb (Fig. 12D) was increased
to a large extent when compared to the limb after ectoderm
removal only (Fig. 12B). These results show that Wnt-6 can
replace the ectoderm in promoting proliferation. Furthermore,
Wnt-6 specifically promotes Pax-3, Paraxis, Myf5, Myogenin,
Desmin and MyHC expression but inhibits expression of
MyoD.Fig. 9. The ectoderm is not only necessary for proliferation but also vital for mainten
25, when the MRFs expression is already established, leads to loss of MyoD (A),
sections show the loss of expression of MyoD, Myf5 and Myogenin in the operated l
E and H respectively). The region without ectoderm is marked within black brackeDiscussion
The onset of limb muscle development is marked by the
migration of muscle precursors from adjacent somites into the
developing limb bud (Christ et al., 1974, 1977; Chevallier et
al., 1977; Ordahl and Le Douarin, 1992). Pax3 is essential in
this process since Pax3 (/) mice lack limb muscle
(Tajbakhsh et al., 1997). Furthermore, the expression of Pax3
precedes that of MyoD and Myf5 (Sassoon et al., 1989;
Tajbakhsh and Buckingham, 1994). This has led to the idea that
Pax3 marks a myogenic precursor population in the limb.
Paraxis is also expressed in migrating myogenic cells, and its
transcripts are localized in an identical pattern to those of Pax3
(Delfini and Duprez, 2000). From the temporal profiles of geneance and differentiation of myogenic cells. Ectoderm removal at HH stages 24–
Myf5 (D) and Myogenin (G) expression after 24 h of reincubation. Transverse
imb (C, F and I respectively) when compared to the unoperated control limb (B,
ts.
Fig. 10. The ectoderm and Wnt-6 promote the expression of Desmin in the limb. (A) Whole-mount immunohistochemistry shows up-regulation of Desmin in the
operated limb (arrowhead) after implantation of Wnt-6-producing cells. (B) Desmin expression in a transverse section of the unoperated limb from panel A. (C)
Expansion of the Desmin expression domain in the transverse section of the operated limb from panel A. (D) Desmin expression after ectoderm removal. The
arrowhead indicates the complete loss of Desmin expression in the operated limb. (E) Transverse section of the unoperated limb in panel D showing normal
expression of Desmin. (F) Transverse section of the operated limb in panel D after ectoderm removal showing absence of Desmin expression (arrowhead). (G)
Desmin expression (arrowhead) after removal of the ectoderm and subsequent implantation of Wnt-6-expressing cells. (H) Expression of Desmin in the unoperated
limb in transverse section. (I) Expression of Desmin in the operated limb (arrowhead) rescued by Wnt-6 after removal of the ectoderm in transverse section.
P. Geetha-Loganathan et al. / Developmental Biology 288 (2005) 221–233 229expression, we and others have suggested that all myogenic
cells originate from the Pax3-positive population (Kablar et al.,
1997; Tajbakhsh et al., 1997; Amthor et al., 1998). When Myf5
transcription is initiated, its expression is very similar to that of
Pax3 (Delfini et al., 2000). In contrast, the expression of MyoD
is restricted to a more central region of the limb. Since both
Myf5 and MyoD have distinct expression profiles, it was
suggested that these genes are controlled independently
(Delfini et al., 2000). Nevertheless, genetic deletion studies
have shown that the genes can compensate for each other as
knockout mice for either gene display normal musculature
(Braun et al., 1992; Rudnicki et al., 1992; Tajbakhsh et al.,
1997). However, deletion of both Myf5 and MyoD results in
animals that lack all skeletal muscle (Rudnicki et al., 1993).Fig. 11. Wnt-6 rescues MRFs expression after ectoderm removal. Application of cells
rescue the expression of Myf5 (D) and Myogenin (G) but not the expression of MyoD
MyoD (B), Myf5 (E) and Myogenin (H). Transverse section of the operated limb
showing rescue of Myf5 (F) and Myogenin (I) expression, whereas Wnt-6 could not
cells expressing GFP-Wnt-6 in the operated limb, and black brackets delimit the reIt is well known that the dorsal and ventral limb ectoderm
influences myogenesis (Gasseling and Saunders, 1961; Zwil-
ling, 1964; Amprino and Amprino-Bonetti, 1967; Stark and
Searls, 1974; Flickinger, 1974; MacCabe et al., 1974; Searls,
1976; Kosher et al., 1979; Searls and Smith, 1982; Bolender et
al., 1993; Dietrich et al., 1998). However, the identities of the
ectodermal molecules capable of regulating muscle develop-
ment have yet to be established. Our previous studies showed
that Wnt-6 is expressed in the dorsal and ventral limb ectoderm
(Rodriguez-Niedenfu¨hr et al., 2003; Loganathan et al., 2005).
This observation led us to investigate whether Wnt-6 could be
involved in regulating limb muscle development.
Our data show that the expression of Myf5 and MyoD (as
well as Pax3, Paraxis, Myogenin, Desmin and MyHC) isexpressing Wnt-6 protein not immediately but 24 h after ectoderm removal can
(A). Transverse section of the unoperated limb showing normal expression of
following application of Wnt-6-expressing cells 24 h after ectoderm removal
rescue the expression of MyoD (C). The green line demarcates the position of
gion devoid of ectoderm.
Fig. 12. The influence of the ectoderm on cell proliferation in the limb. (A) BrdU incorporation in a transverse section of a normal stage 26 wing bud at medial level.
(B) BrdU incorporation at stage 26 after dorsal ectoderm removal at stage 21 (extent of ectodermal removal indicated by arrowheads). (C) BrdU incorporation in a
transverse section of a normal stage 25 wing bud. (D) Rescue of proliferative activity by Wnt-6, shown by the presence of BrdU-positive cells at stage 25 after dorsal
ectoderm removal and implantation of Wnt-6-producing cells (extent of ectodermal removal marked by arrowheads).
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show that, even after the establishment of Myf5 and MyoD
expression, the ectoderm is still required to maintain transcrip-
tion of these genes. Surprisingly, Myf5 and MyoD respond
differently to the ectodermal signal Wnt-6. Our data show that
over-expression of Wnt-6 leads to an up-regulation of Myf5 as
well as Pax3 and Paraxis. Furthermore, we show that Wnt6
can substitute for the ectoderm in its capacity to promote Myf5
expression. In contrast, Wnt6 down-regulates the expression of
MyoD. These results support the notion that two molecular
pathways control limb muscle development. In both pathways,
cells originate from myogenic precursors expressing Pax3, one
pathway gives rise to cells that express Myf5 and not MyoD,
whereas the second pathway gives rise to cells which express
MyoD and not Myf5. Unlike the data presented here, MyoD
and Myf5 expression was shown to be induced by Wnt-6 in
mouse paraxial mesoderm explants (Tajbakhsh et al., 1998).
These conflicting results cannot be fully explained to date.
They might be due to the species-specific peculiarities of MRF
expression in avian and mouse embryos and/or to difference
between muscle differentiation in the trunk and in the limbs.
Interestingly, addition of exogenous Wnt-6 restores the
expression pattern of the proliferative markers, the induction is
strongest distally where precursor cells are likely to be located.
This type of effect is also seen with Myf5. These genes
represent pre-differentiation markers expected for precursor
cells. Differentiation-specific probes (Myogenin/Desmin), by
contrast, do not show such a distal-specific effect because they
represent the daughters of the precursor cell and they are
located in a more proximal position.
We show that the proliferative activity of mesenchymal cells
is completely lost after ectoderm removal, shown by the drastic
reduction in the rate of BrdU incorporation. This is in
agreement with previous studies (Amthor et al., 1998).
However, here, we show that Wnt-6 can rescue the prolifer-ation of mesodermal cells in the absence of the ectoderm. This
study, together with previous work, shows that Wnt-6 can
influence the development of numerous mesenchymal tissues.
Furthermore, cells from differing locations respond in distinct
ways to Wnt-6. It has been previously shown that Wnt-6
induces somitic cells to remain in an epithelial state and not to
migrate from the somite, whereas, in the limb, muscle
precursor cells appear to move normally (Schmidt et al.,
2004) and become arranged as dense clusters, thus providing a
community effect that promotes muscle differentiation (Gurdon
et al., 1993).
One interesting aspect of this work concerns the fate of the
myogenic cells following ectoderm ablation which, as we have
shown, not only leads to a decrease of proliferation but also to a
complete loss of expression of Pax3, Paraxis, Myf5, MyoD,
Myogenin, Desmin and MyHC. We show that injection of cells
expressing Wnt-6 even 24 h after ectoderm removal leads to a
rescue of expression of Myf5 but not MyoD. This shows that
(1) the ectoderm does not supply a myogenic survival factor
and (2) the myogenic identity is maintained even following the
loss in expression of Pax3, Paraxis, Myf5 and MyoD. The
Myf5 expression domains in these rescue experiments were
never as large as the control side probably due to the fact that
the rate of proliferation had been switched off for 24 h.
Our experiments show that Wnt-6 can promote limb
myogenesis. Misexpression of the Wnt antagonist Sfrp-2,
which is expressed by uncommitted myogenic precursors,
decreased myocyte number both in vivo and in vitro (Anakwe
et al., 2003). However, over-expression of Sfrp-2 resulted in
the down-regulation of both Myf5 and MyoD expression (data
not shown), suggesting that Wnt signaling is needed for the
onset of MRF expression (Anakwe et al., 2003). It has been
reported that the Sfrp-2 inhibitory effect is selective to Wnt1
and Wnt4, but not Wnt3a (Ladher et al., 2000; Lee et al.,
2000). Similarly, Sfrp-2 may not be specific in antagonizing
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signaling molecule that promotes MyoD expression during
limb myogenesis. As in our experiments, the expression of
MyoD was lost after ectoderm removal and following the
application of a Wnt antagonist, it is likely that a member of the
Wnt family (but not Wnt-6) expressed in the ectoderm
regulates expression of MyoD. Although Wnt7a is expressed
in the ectoderm of the limb bud, it is unlikely to be the
regulator of MyoD expression since it is only expressed in the
dorsal ectoderm of the chick limbs (Dealy et al., 1993). The
Myf5 expression domain closely resembles that of Pax3, which
extends near the ectoderm, whileMyoD mRNA is located more
centrally within the limb. This leads us to speculate that there
exists an unknown MyoD-inducing factor in the limb
mesenchyme which is activated by ectodermal signaling.
Experiments are underway in our laboratory to elucidate the
problem of MyoD induction during limb myogenesis.
Taken together, we show that the limb ectoderm is essential
for the expression of all myogenic markers in the developing
limb and that Wnt-6 is a signal from the ectoderm that
promotes initiation, proliferation, maintenance and differenti-
ation of limb muscle cells. We propose a model on the genetic
regulation of limb myogenesis (Fig. 13) in which two parallel
pathways exist during limb myogenesis. Myogenic cells can be
generated independently by Myf5 and MyoD (Rudnicki et al.,
1992, 1993; Braun and Arnold, 1994; Kablar et al., 1997;
Tajbakhsh et al., 1997). Either gene activity leads to the
activation of Myogenin and subsequently to the activation of
Desmin and MyHC expression. Pax3 and Paraxis are both
upstream of MyoD and Myf5. This model is in line with the
findings that Myf5 and MyoD are not expressed at detectable
levels in the presumptive myogenic precursor cells migrating
from the somite to the limb bud (Sassoon et al., 1989;Fig. 13. Schematic representation of an epitasis model of limb myogenesis.
Blue arrows indicate positive inductions, while blue line with bar represents
inhibitory actions. Black arrows mark the sequence of myogenic program.
According to this model, there exist two parallel pathways in limb myogenesis
during development. Myogenic cells initially express Pax3 and Paraxis
initially. Pax3/Paraxis activity leads to the induction of Myf5 or MyoD. Either
gene activity (Myf5 and MyoD) leads to the activation of Myogenin and
subsequently to the activation of Desmin, thus leading eventually to the
formation of functional myocytes. Putative signals activating the expression of
genes involved in both of the two pathways originate from the ectoderm. The
Wnt-6 signal from the ectoderm promotes Myf5-dependent myogenesis by
specifically inducing the activation of the Pax3/Paraxis–Myf5 pathway and by
inhibiting theMyoD pathway. Other putative signals that promote the activation
of the MyoD pathway may include other Wnts or unknown (X) factors which
are yet to be elucidated.Tajbakhsh and Buckingham, 1994), but these migratory cells
express Pax3 (Williams and Ordahl, 1994) and are believed to
be determined towards the muscle lineage (Tajbakhsh and
Buckingham, 1994). Furthermore, Myf5 and MyoD are not
expressed until after the Pax3-expressing migratory cells have
arrived in the limb bud (Sassoon et al., 1989; Tajbakhsh and
Buckingham, 1994). Myf5 and MyoD have distinct expression
patterns, implying that their regulatory sequences are different
and that they probably respond to different signaling mole-
cules. Our results do not support the notion that Myf5 always
acts upstream of MyoD during limb muscle development
(Delfini et al., 2000). In our experiment in which Wnt-6 led to
the induction of Myf5, we never detected the expression of
MyoD, even though muscle went on to terminal differentiation.
However, the possibility that Wnt-6 could inhibit transition
from Myf5 to MyoD cannot be excluded as it was shown that
they can compensate for each other (Rudnicki et al., 1992;
Tajbakhsh and Cossu, 1997). However, the positive influence
of Wnt-6 on the expression of muscle differentiation markers
but an inhibitory action on MyoD expression clearly shows that
MyoD pathway runs in parallel to that of Myf5 pathway during
limb myogenesis. In MyoD null background, Myf5 is haploin-
sufficient, two functional alleles being more efficient in
programming myogenesis. The presence of muscle in the
absence of MyoD, and the finding that Pax-3 mutants do not
develop muscle whereas homozygous mutant embryos for
either MyoD or Myf5 develop normally, suggests that Myf5 and
MyoD are not functionally reductant transcription factors but
that they can compensate for each others functions (Rudnicki et
al., 1992, 1993; Tajbakhsh and Cossu, 1997) also adds support
to our view. In this work, we show that Wnt-6 protein initiates
the Pax3/Paraxis –Myf5 pathway, while MyoD induction is
negatively regulated by Wnt-6 signaling. Induction of MyoD
expression may require other members of the Wnt family or
other yet unknown signaling proteins.
Amthor et al. (1998, 1999) have shown that epaxial and
hypaxial muscle development is dependent on BMP signals
produced by the limb ectoderm and the subectodermal
mesenchyme. These data lead us to suggest an interaction
of BMP and Wnt signaling. It has been shown by Burstyn-
Cohen et al. (2004) that BMP4 can modulate Wnt signaling.
Fan et al. (1997) have demonstrated that Wnt-6 can directly
induce dermomyotome marker expression. It is therefore
likely that the expression of Wnts in the limb ectoderm is
induced and maintained by BMPs and other signaling
molecules produced by the subectodermal mesoderm. The
results from this study are in line with previous data
originating from our group. Amthor et al. (1998) showed
that ectoderm removal inhibits muscle growth by depriving
precursor cells of the proliferative signals, resulting in
premature differentiation as detected by a short-lived burst
in MyoD expression. Since MyoD expression was observed
only 10 h after ectoderm removal and to rule out the timing
influence of ectodermal signaling on MyoD expression, the
same experiment as in Amthor et al. (1998) was performed,
but the embryos were reincubated for different time periods.
As in the experiment, the operated limb was left uncovered,
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margins and a smaller region devoid of ectoderm (data not
shown). The seeming difference in results in Amthor et al.
(1998) and this study can be explained by the existence of
two differently acting signals emanating from the ectoderm.
We hypothesize that a short range acting signal induces Pax3
but inhibits MyoD expression and another long range
diffusible signal induces MyoD expression in the limb. We
observed a short-lived burst of MyoD expression induced by
the putative long range signal arising from the ectoderm that
has partially regenerated in the absence of gold foil. In the
present study, regeneration of ectoderm was ruled out by the
use of gold foil which kept the limb free of dorsal ectoderm.
Therefore, no long range MyoD inducing signal was present,
resulting in a loss of MyoD expression. The interruption of
the directly acting short range signal due to ectoderm removal
led to immediate loss of Pax3 expression. Moreover, the
expression of Pax3 close to the ectoderm and MyoD deeper
in the limb mesenchyme (Amthor et al., 1998; Delfini et al.,
2000) is in line with the existence of two differently acting
signals emanating from the ectoderm. Together, these studies
highlight two important functions of Wnt-6: (1) to promote
the proliferation of myogenic precursor cells and (2) to
prevent cells from entering the MyoD differentiation pathway.
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